Recent Updates
Recently added Catalysts
PTCT Positive Sentiment

PTC Therapeutics Announces Virtual Presentation on Phenylketonuria (PKU) and Sepiapterin PTC Therapeutics, Inc. (NASDAQ: PTCT), announced today that the company will provide a virtual presentation on PKU including discussion of the...

Tuesday, July 11, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: PTC Therapeutics, Inc. (NASDAQ: PTCT) has announced a virtual presentation focused on Phenylketonuria (PKU) set for July 19, 2023. The event will feature discussions on the therapeutic landscape and the company's clinical program for sepiapterin. A key opinion leader, Dr. Ania C. Muntau, will participate, alongside senior management from PTC. Attendees will also have the opportunity to engage in a Q&A session following the presentation.
Price reaction · baseline $40.27 (2023-07-10 close) · hit after-hours · clean, no other PTCT news in the window
day 0 close
-0.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • PTC Therapeutics is engaging with experts through a virtual presentation.
  • The presentation will cover the current therapeutic landscape for PKU.
  • Discussion will include the clinical program for sepiapterin.
  • Key opinion leaders will be involved, enhancing credibility.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+74%
120-day peak, hindsight
Typical move
6.6%
average across 4 past catalysts
Lead asset
Ataluren
Phase 3 · Cystic Fibrosis

Full Press Release Details

SOUTH PLAINFIELD, N.J. , July 11, 2023 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT ), announced today that the company will provide a virtual presentation on PKU including discussion of the current therapeutic and commercial landscape with an expert key opinion leader. In addition, the company will discuss the sepiapterin clinical program followed by a Q&A session. The event will occur on Wednesday, July 19 , from 12 to 1:30 p.m. ET . Presenters will include Ania C. Muntau, MD, Professor of Pediatrics, Chair, University Children's Hospital, University Medical Center, Hamburg Eppendorf, Germany , and PTC senior management.
Conference Call and Webcast Information To access the call by phone, please click here to register and you will be provided with dial-in details. To avoid delays, we recommend participants dial in to the conference call 15 minutes prior to the start of the call. The webcast conference call can be accessed on the Investor section of the PTC website at https://ir.ptcbio.com/events-presentations . A replay of the call will be available approximately two hours after completion of the call and will be archived on the company's website for 30 days following the call.
For More Information:

Frequently Asked Questions

When is the PTC Therapeutics virtual presentation on PKU?

The virtual presentation will occur on July 19, 2023, from 12 to 1:30 p.m. ET.

Who will present at the PKU discussion event?

The event will feature Dr. Ania C. Muntau and PTC senior management.

How can I access the PTC conference call?

Participants can register online to receive dial-in details for the call.

Is there a replay available for the conference call?

Yes, a replay will be available two hours after the call and lasts for 30 days.

Where can I find more information about the event?

More details about the event can be found on the Investor section of PTC's website.

ShareAdd on Google
Tags: PTCT Viatris Investor Conferences Healthcare PTC Therapeutics PKU Sepiapterin virtual presentation medical discussion
Last updated: Jul 11, 2023

Biotech snapshot

Cash runway
$2229M liquidity · $0M/mo burn
Low dilution risk
Lead asset
AtalurenPhase 3
Cystic Fibrosis →

Catalyst track record

+74%
best trade around PTCT's most recent catalyst

Peak hindsight return over a 120-day window, across 4 tracked FDA/PDUFA catalysts for PTCT.

See every catalyst's timing & PoA →